You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 7, 2024

MAGNESIUM SULFATE IN DEXTROSE 5% IN PLASTIC CONTAINER Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Magnesium Sulfate In Dextrose 5% In Plastic Container patents expire, and what generic alternatives are available?

Magnesium Sulfate In Dextrose 5% In Plastic Container is a drug marketed by B Braun Medical Inc, Baxter Hlthcare Corp, Fresenius Kabi Usa, Hospira, Hq Spclt Pharma, and Mylan Labs Ltd. and is included in six NDAs.

The generic ingredient in MAGNESIUM SULFATE IN DEXTROSE 5% IN PLASTIC CONTAINER is magnesium sulfate. There are one hundred and forty-six drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the magnesium sulfate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Magnesium Sulfate In Dextrose 5% In Plastic Container

A generic version of MAGNESIUM SULFATE IN DEXTROSE 5% IN PLASTIC CONTAINER was approved as magnesium sulfate by FRESENIUS KABI USA on September 8th, 1986.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for MAGNESIUM SULFATE IN DEXTROSE 5% IN PLASTIC CONTAINER?
  • What are the global sales for MAGNESIUM SULFATE IN DEXTROSE 5% IN PLASTIC CONTAINER?
  • What is Average Wholesale Price for MAGNESIUM SULFATE IN DEXTROSE 5% IN PLASTIC CONTAINER?
Summary for MAGNESIUM SULFATE IN DEXTROSE 5% IN PLASTIC CONTAINER
Drug patent expirations by year for MAGNESIUM SULFATE IN DEXTROSE 5% IN PLASTIC CONTAINER
Recent Clinical Trials for MAGNESIUM SULFATE IN DEXTROSE 5% IN PLASTIC CONTAINER

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University of OklahomaEarly Phase 1
Daewoong Pharmaceutical Co. LTD.Phase 3
Cairo UniversityPhase 1/Phase 2

See all MAGNESIUM SULFATE IN DEXTROSE 5% IN PLASTIC CONTAINER clinical trials

US Patents and Regulatory Information for MAGNESIUM SULFATE IN DEXTROSE 5% IN PLASTIC CONTAINER

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
B Braun Medical Inc MAGNESIUM SULFATE IN DEXTROSE 5% IN PLASTIC CONTAINER magnesium sulfate INJECTABLE;INJECTION 207966-001 Oct 27, 2020 AP RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Mylan Labs Ltd MAGNESIUM SULFATE IN DEXTROSE 5% IN PLASTIC CONTAINER magnesium sulfate INJECTABLE;INJECTION 209932-001 Sep 10, 2018 AP RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Hospira MAGNESIUM SULFATE IN DEXTROSE 5% IN PLASTIC CONTAINER magnesium sulfate INJECTABLE;INJECTION 020488-001 Jul 11, 1995 AP RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Baxter Hlthcare Corp MAGNESIUM SULFATE IN DEXTROSE 5% IN PLASTIC CONTAINER magnesium sulfate INJECTABLE;INJECTION 211965-001 Aug 11, 2020 AP RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.